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Sirtuins are a class of enzymes originally identified as nicotinamide adenine dinucleotide (NAD)-dependent
protein lysine deacetylases. Among the seven mammalian sirtuins, SIRT1-7, only SIRT1-3 possess
efficient deacetylase activity in vitro, whereas SIRT4-7 possess very weak in vitro deacetylase activity. Several
sirtuins that exhibit weak deacetylase activity have recently been shown to possess more efficient activity for
the removal other acyl lysine modifications, such as succinyl lysine and palmitoyl lysine. Here, we
demonstrate that even the well-known deacetylase SIRT2 possesses efficient activity for the removal of
long-chain fatty acyl groups. The catalytic efficiency (kcat/Km) for the removal of amyristoyl group is slightly
higher than that for the removal of an acetyl group. The crystal structure of SIRT2 in complex with a
thiomyristoyl peptide reveals that SIRT2 possesses a large hydrophobic pocket that can accommodate the
myristoyl group. Comparison of the SIRT2 acyl pocket to those of SIRT1, SIRT3, and SIRT6 reveals that the
acyl pockets of SIRT1-3 are highly similar, and to a lesser degree, similar to that of SIRT6. The efficient in
vitro demyristoylase activity of SIRT2 suggests that this activity may be physiologically relevant and
warrants future investigative studies.
S
irtuins, which are represented by the foundingmember yeast SIR2 (silencing information regulator 2), are a
class of enzymes that possess Nicotinamide Adenine Dinucleotide (NAD1)-dependent protein lysine
deacetylase activity and were originally discovered in the aging and epigenetic fields1. Sirtuins regulate
numerous biological pathways by deacetylating various substrate proteins, including histones, transcription
factors, and metabolic enzymes2–4. Mammals possess seven sirtuins, SIRT1-75, which share a conserved catalytic
core domain but differ in their N- and C- termini. SIRT1, 6 and 7 are located in the nucleus. SIRT3, 4 and 5 are
located in mitochondria and are involved in energy metabolism and responses to oxidative stress. SIRT2 is the
only primarily cytoplasmic isoform6; however, it has also been observed in the nucleus.
Among the seven sirtuins, only SIRT1-3 (belonging to class I sirtuins) possess efficient deacetylase activity
in vitro7, whereas SIRT4–7 exhibit little or undetectable deacetylation activity. Recently, we have demonstrated
that SIRT5, which is a class IIImitochondrial sirtuin that exhibits weak deacetylase activity, can efficiently remove
negatively charged acyl groups, such as succinyl and malonyl groups, due to the presence of an Arg and a Tyr in
the SIRT5 active site8. Although protein lysine succinylation andmalonylation have not been previously known as
common protein posttranslationalmodifications, it is currently established that thesemodifications are abundant
in both bacteria andmammals9–12.We have also demonstrated that SIRT6, which is a class IV sirtuin that exhibits
weak deacetylase activity, can remove long-chain fatty acyl groups more efficiently13. These studies have estab-
lished that sirtuins are NAD-dependent protein lysine deacylases and that different sirtuins may exhibit different
acyl group preferences.
The defatty-acylase activity of sirtuins may be more widespread. A malaria parasite SIR2, PfSIR2A, was also
shown to possess a similar activity toward long-chain fatty acyl groups14. Perhaps more surprisingly, we and
others have recently found that even SIRT1-3, which exhibit efficient deacetylase activities, can also remove long-
chain fatty acyl groups15,16. However, the efficiency and physiological relevance of this activity of SIRT1-3 are not
known. Here, we sought to determine the efficiency of the defatty-acylase activity compared to the deacetylase
activity of SIRT2 and the structural basis for the recognition of long-chain fatty acyl groups by SIRT2. Our study
reveals that SIRT2 prefers myristoyl lysine as a substrate slightly over acetyl lysine. A crystal structure of SIRT2 in
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fatty acyl groups. Our studies demonstrate that the defatty-acylase
activity of SIRT2 is highly efficient and provide compelling rationale
for future studies on the physiological relevance of this activity.
Results
SIRT2 can remove long-chain fatty acyl groups from different
peptide sequences. Previous studies demonstrating the defatty-
acylase activity of SIRT1-3 only used one peptide sequence15,16. We
first evaluated whether SIRT2 can demyristoylate different peptide
sequences. In addition to histone H3 Lys9 (H3K9)17 (Figure 1a)
peptides, we synthesized histone H2B Lysine12 (H2BK12) and
histone H4 Lysine16 (H4K16) peptides bearing acetyl and myris-
toyl groups. The SIRT2 protein used herein consists of residues
38–356 of the full-length human SIRT2. SIRT2 was able to re-
move both acetyl and myristoyl groups from H2BK12 (Figure 1b)
and H4K16 (Figure 1c) peptides without a strong sequence bias,
suggesting that SIRT2 may exert demyristoylase activity toward a
wide range of substrates. Compared with the deacetylase activity,
the demyristoylase activity of SIRT2 requires a longer time to
reach a similar conversation rate (Figure 1), suggesting that the kcat
of demyristoylation is lower than that of deacetylation.
The demyristoylase activity of SIRT2 is more efficient than its
deacetylase activity. To quantitatively compare the activity of
SIRT2 toward acetyl and long-chain fatty acyl peptides, we
performed kinetics studies using acetyl and myristoyl H3K9
peptides, respectively. As shown in Table 1, although the kcat for
deacetylation (0.275 s21) was 15-fold higher than that for
demyristoylation (0.018 s21), the Km for deacetylation (19.00 mM)
was approximately 80-fold higher than that for demyristoylation
(0.24 mM). Therefore, kcat/Km for demyristoylation (74,000
s21M21) was approximately 5-fold higher than that for deacety-
lation (14,500 s21M21).
Crystal structure of SIRT2 in complex with a thiomyristoyl
peptide, BHJH-TM1. To further understand the defatty-acylase
activity of SIRT2, we sought to obtain an X-ray crystal structure of
SIRT2 in complexwith amyristoyl peptide substrate or analog. Upon
screening of crystallization conditions, we obtained crystals of SIRT2
in complex with a thiomyristoyl peptide, referred to as BHJH-TM1
(Figure 2A). BHJH-TM1 was synthesized as a mechanism-based
inhibitor of SIRT1-3 and SIRT616. The crystal structure of SIRT2/
BHJH-TM1was refined to a resolution of 2.1 A˚, with two subunits in
the asymmetric unit. Most of the residues (residues 55–355 from
chain A and residues 54–355 from chain B) fit well in the observed
electron density, except for the loop regions consisting of residues
293–305 in both subunits, residues 139–140 in chain A and residues
98–101 in chain B.
As observed in the crystal structures of apo SIRT2 and other
sirtuins, SIRT2/BHJH-TM1 consists of two distinct domains: a
Rossmann fold domain and a zinc-binding domain. The BHJH-
TM1 peptide inserts into a large groove between the two domains
(Figure 2B).
BHJH-TM1 binding site of SIRT2. The BHJH-TM1 peptide
(PKK(TMy)TG) consists of five amino acid residues (Figure 2A)
with a thiomyristoyl group attached to the central lysine residue.
The BHJH-TM1 peptide fits well into a long stretch of electron
density observed between the N-terminal Rossmann fold domain
and C-terminal zinc-binding domain of SIRT2 (Figure 3A). The
binding mode of the BHJH-TM1 peptide to SIRT2 is similar to
that observed for other sirtuins (e.g., Archaeoglobus fulgidus SIR218
and human SIRT58) and predominantly involves the following
hydrogen bonds (Figure 3B): the main chain NH and CO of the
thiomyristoyl lysine form hydrogen bonds with the main chain CO
of Glu237 and the main chain NH of Gly236, respectively; the main
chain NH and CO of threonine form hydrogen bonds with the main
chain CO and NH of Gln267, respectively; and the Ne of the free
lysine side chain forms a hydrogen bond with the side chain OH of
Ser238 (Figure 3B). Compared to the apo SIRT2 structure, all four
residues involved in these hydrogen bonds lie far from the BHJH-
TM1molecule in the apo SIRT2 structure. This finding indicates that
the entrance of the binding site is more open prior to substrate
binding, facilitating substrate access.
In both active sites of the two subunits, the BHJH-TM1molecule is
finely complementary to the site in terms of both shape and charge
(Figure 3C). The thiomyristoyl group of BHJH-TM1 is accommo-
dated by a hydrophobic pocket formed by several hydrophobic resi-
dues of SIRT2, including Ile93, Phe96, Phe119, Phe131, Leu134,
Leu138, Phe143, Ile169, Phe190, Ile232, and Phe234 (Figure 3D).
The extensive hydrophobic interactions between the thiomyristoyl
group and SIRT2may account for themuch lowerKm value of SIRT2
toward the myristoyl lysine peptide (Table 1).
Comparison of the apo SIRT2 and SIRT2/BHJH-TM1 structures.
Comparison of the overall structures of SIRT2/BHJH-TM1 and apo
SIRT2 (PDB ID: 3ZGO) indicates that the zinc-binding domain
moves approximately 10 A˚ toward the groove, closing the binding
site in the SIRT2/BHJH-TM1 structure (Figure 4A). A similar
conformational change was also observed in SIRT119. Comparison
of the active sites of SIRT2/BHJH-TM1 and apo SIRT2 (Figure 4B)
reveals that the hydrophobic residues from the Rossmann fold
domain that form the myristoyl pocket (e.g., Ile93, Phe143, and
Ile169; Figure 4B) superpose relatively well, whereas the hy-
drophobic residues from the zinc-binding domain (e.g., Phe131,
Leu138, and Phe234) move approximately 3–4 A˚ between the apo
SIRT2 structure and the SIRT2/BHJH-TM1 structure (Figure 4B).
This conformational change reshapes the binding site, which may
better accommodate the thiomyristoyl group.
Comparison of the SIRT2/BHJH-TM1 structure with the struc-
tures of SIRT3 and SIRT6.We have previously reported that SIRT6
prefers to hydrolyze long-chain fatty acyl groups from protein lysine
residues in vitro. As observed in SIRT2, SIRT6 also possesses a large
hydrophobic pocket that accommodates the long-chain fatty acyl
groups13. We superposed the structures of SIRT2 and SIRT6 (PDB
ID: 3ZG6) to compare their acyl pockets. Although the Rossmann
fold domains and the bound acyl lysine peptides superpose relatively
well, the structures of the SIRT2 and SIRT6 zinc-binding domains
are quite different (Figure 5A). The hydrophobic residues that form
the acyl pockets are also very different (Figure 5B). For example,
Met134 in SIRT6 corresponds to the position of Phe190 in SIRT2,
and Asn2 and Trp69 in SIRT6 occupy the corresponding position of
Phe119 in SIRT2. Most strikingly, Phe84 in SIRT6 occupies a
position that would sterically clash with the more extended
thiomyristoyl group (green color, Figure 5B) in the SIRT2
structure. Phe84 in SIRT6 forces the myristoyl group in complex
with SIRT6 to adopt a more bent conformation (purple color,
Figure 5B). Despite these differences (in terms of shape and
residues involved) between the two acyl pockets in SIRT2 and
SIRT6, these pockets lie at approximately similar locations in both
proteins to accommodate the long-chain fatty acyl groups. Because
hydrophobic side chains are critical for the formation of an acyl
pocket, it is perhaps not surprising that the residues that form the
acyl pockets in SIRT2 and SIRT6 are different.
Comparison of the overall structures of SIRT2/BHJH-TM1 with
SIRT3 (PDB ID: 3GLT)20 or SIRT1 (PDB ID: 4KXQ)19 reveals that
the structures are highly similar (Figures 5C and 5E). The acyl pock-
ets are also highly similar (Figures 5D and 5F). Several of the hydro-
phobic residues that form the acyl pocket are identical. For example,
Phe293, Ile291, Phe192 and Phe251 in SIRT3 superpose well with
Phe234, Ile232, Phe131, and Phe190 of SIRT2, respectively
(Figure 5D). The most notable difference between the SIRT3 (or
SIRT1) acyl pocket and the SIRT2 acyl pocket is that Leu199 of
www.nature.com/scientificreports
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Figure 1 | Overlaid HPLC traces showing that SIRT2 could hydrolyze acetyl and myristoyl groups from different peptide sequences, H3K9 (a),
H2BK12 (b) and H4K16 (c). The unmodified, acetylated and myristoylated peptides are indicated by the red, blue and black arrows, respectively.
www.nature.com/scientificreports
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SIRT3 (or Ile316 of SIRT1) lies much closer to the thiomyristoyl
group than the corresponding Leu138 of SIRT2, which may result
in steric clashes (Figures 5D and 5F). This potential steric clash may
force the myristoyl group to turn toward or into the empty space
beneath Leu164 of SIRT3 (or Ile279 of SIRT1), creating a bent myr-
istoyl conformation that is similar to that observed in SIRT6, as
shown in Figure 5B. Given that SIRT3 and SIRT1 can also hydrolyze
long-chain fatty acyl groups, this structural comparison provides a
reasonable model for the recognition of long-chain fatty acyl groups
by SIRT3 and SIRT1.
Discussion
We have demonstrated that SIRT2 is an efficient demyristoylase in
vitro. The catalytic efficiency of SIRT2 for the hydrolysis of myristoyl
lysine is slightly higher than that for deacetylation. This increased
catalytic efficiency originates primarily from the decreased Km
values. In contrast, the kcat value for demyristoylation is lower than
that for deacetylation. The crystal structure of SIRT2 in complexwith
a thiomyristoyl peptide, BHJH-TM1, reveals a larger hydrophobic
pocket that is responsible for binding the long-chain fatty acyl
groups. The hydrophobic acyl pocket of SIRT2 resembles that of
SIRT6, which is a sirtuin that has been previously demonstrated to
possess efficient defatty-acylase activity, although the two acyl pock-
ets differ in certain aspects. In addition, the hydrophobic acyl pocket
of SIRT2 is highly similar to that of SIRT1 and SIRT3, thus providing
a reasonable model to account for the ability of SIRT1 and SIRT3 to
remove long-chain fatty acyl groups. Moreover, SIRT1, SIRT2 and
SIRT3 can remove lipoic acid based on assays utilizing [32P]NAD121.
For other long-chain fatty acyl substrates, such as hexanoyl, octanoyl,
and decanoyl groups, SIRT2 also exhibits defatty-acylase activity;
however, the defatty-acylase activity toward palmitoyl groups is
not efficient, which may result from the limited depth of the active
site.
Sirtuins are classified into four different classes based on sequence
similarity5. SIRT1-3, which were previously thought be primarily
deacetylases, all belong to class I. SIRT4, which does not exhibit
efficient activity in vitro, belongs to class II. The desuccinylase/dema-
lonylase/deglutarylase SIRT5 belongs to class III. SIRT6 (preferen-
tially a defatty-acylase in vitro) and SIRT7 both belong to be class IV.
Our kinetic and structural studies on SIRT2 suggest that the defatty-
acylase activity of SIRT2 (and likely that of SIRT1 and SIRT3) is
equally efficient, if not more efficient, than the deacetylase activity.
Thus, class I sirtuins have likely evolved to recognize both short and
long-chain fatty acyl groups. Class IV sirtuins, particularly SIRT6,
exhibit a preference for long-chain fatty acyl groups, at least in vitro.
However, several studies suggest that the deacetylase activity is
important in vivo. Class III sirtuins preferentially recognize nega-
tively charged acyl groups. Human SIRT5 is specific for negatively
charged acyl groups, such as malonyl, succinyl, and glutaryl groups.
However, certain class III members, such as Escherichia coli CobB,
may be multifunctional and can remove different acyl groups (such
as succinyl and acetyl) with similar efficiency22. Thus, it appears that
many sirtuins can exhibit promiscuous activities toward different
acyl lysine modifications.
Our kinetic and structural analyses of SIRT2 suggest that the
defatty-acylase activity may be physiologically relevant. A recent
study shows that SIRT2 can regulate protein lysine fatty-acylation
in cells23. The physiological relevance of this defatty-acylase activity
is particularly interesting for several reasons. First, this activity is
primarily localized in the cytosol (in contrast to SIRT1, which is
primarily nuclear, and SIRT3, which is primarily mitochondrial)7.
Most known protein fatty acyl modifications, such as N-terminal
glycine myristoylation and cysteine palmitoylation, occur in the
cytosol or the cytosolic face of the ER and Golgi24. Therefore, it is
reasonable to speculate that numerous lysine fatty acylation events
will also occur in the cytosol and be regulated by cytosolic SIRT2.
Second, in contrast to SIRT1, for which numerous deacetylation
substrates have been identified, relatively few deacetylation sub-
strates of SIRT2 have been reported. These SIRT1 substrates include
a-tubulin25, histones H3 and H426–28, lactate dehydrogenase A29,
BubR130, and HIF-1a31. Consistent with this observation, proteomic
studies on both SIRT1 and SIRT3 have reported the identification of
hundreds of substrates32–34, in contrast to the lack of similar studies
for SIRT2. The limited number of identified deacetylation substrates
for SIRT2may reflect an as-of-yet unidentified biochemical function.
Efforts to identify the defatty-acylation substrate of SIRT2 are cur-
rently ongoing.
Methods
Materials. Acetyl and myristoyl peptide substrates used in the SIRT2 assay were
synthesized as previously reported. The thiomyriostyl peptide BHJH-TM1 was
synthesized as a mechanism-based inhibitors for SIRT1-3 and SIRT6 as recently
reported16.
Table 1 | Kinetics data for SIRT2 on acetyl and myristoyl H3K9 peptides
Acyl peptide kcat (s21) Km (mM) kcat/Km (s21M21)
H3K9 acetyl 0.275 6 0.014 19.00 6 0.85 14500
H3K9 myristoyl 0.018 6 0.003 0.24 6 0.03 74000
Figure 2 | Overall Structure of SIRT2 in complex with a thiomyristoyl
peptide, BHJH-TM1. (A) Structure of the BHJH-TM1. (B) The
overall structure of SIRT2/BHJH-TM1 complex.
www.nature.com/scientificreports
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Figure 3 | The active site of SIRT2/BHJH-TM1. (A) Electron density map of the BHJH-TM1. The 2Fo-Fc map is colored in grey and contoured at
1.5 s. (B) The hydrogen bonding interactions between SIRT2 and BHJH-TM1. (C) Surface representation of myristoyl-binding pocket. The surface
potential is displayed as a color gradient from red (negative) to blue (positive). (D) Hydrophobic residues (colored cyan) of SIRT2 that are involved in
binding the thiomyristoyl group of BHJH-TM1.
Figure 4 | Substrate binding triggers the formation of a closed state of SIRT2. (A) Alignment of SIRT2 apo structure (purple) and SIRT2/BHJH-TM1
structure (cyan). The apo structure is more open. Upon substrate binding, the zinc binding domain (top) moves toward the Rossmann fold
domain to bind the substrate analog BHJH-TM1. (B)Detailed view of the residues forming the acyl pocket also reveals themovement of the residues from
the top zinc-binding domain towards the lower Rossmann fold domain. The substrate analog BHJH-TM1 is shown in green stick representation and for
clarity, the side chains are not shown except for the thiomyristoyl lysine.
www.nature.com/scientificreports
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Figure 5 | Structural comparison between SIRT2 and SIRT6 (PDB 3ZG6)/SIRT3 (PDB 3GLT). (A) Overall structural alignment of SIRT2 (cyan)
and SIRT6 (wheat). (B) Detailed view of the acyl pockets of SIRT2 and SIRT6. The myristoyl group in SIRT6 structure is shown in purple, the
thiomyristoyl group in SIRT2 structure is shown in green. Residues from SIRT6 are shown in wheat, while residues from SIRT2 are shown in cyan.
(C)Overall structural alignment of SIRT2 (cyan) and SIRT3 (yellow). (D) Detailed view of the acyl pockets of SIRT2 and SIRT3. The thiomyristoyl group
in SIRT2 structure is shown in green. Residues from SIRT3 are shown in yellow, while residues from SIRT2 are shown in cyan. (E) Overall structural
alignment of SIRT2 (cyan) and SIRT1 (brown). (F) Detailed view of the acyl pockets of SIRT2 and SIRT1. The thiomyristoyl group in SIRT2 structure is
shown in green. Residues from SIRT1 are shown in brown, while residues from SIRT2 are shown in cyan.
www.nature.com/scientificreports
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Overexpression and Purification of SIRT2. The Sirt2 gene fromHomo.Sapiens was
cloned into a pET28b(1) (Novagen) vector containing an N-terminal hexahistidine
and sumo tag. SIRT2 was overexpressed in E. coli BL21 (DE3) grown in Luria-Bertani
(LB) media. The cells were grown at 37uC to an OD600 of ,0.6 and induced with
0.2 mM isopropyl 1-b-D-galactopyranoside (IPTG) for 18–24 h at 18uC. Cell pellets
from 2 L of culture were lysed by sonication on ice in 20 mM Tris, 200 mM NaCl,
pH7.5. The resulting supernatants were loaded onto a Ni-NTA column and the
column was washed with 10 column volumes of buffer containing 20 mM Tris,
200 mM NaCl, and 20 mM imidazole, pH 7.5. The bound SIRT2 was eluted with
20 mM Tris, 200 mM NaCl, and 250 mM imidazole, pH 7.5. The eluted protein
fractions were cleavage by Ulp1 overnight, then loaded onto a Ni-NTA column and
collected the flow out solution. The solution were incubated with 10 mMMyr Peptide
(PKK(Tmy)TG) and 2 mM dithiothreitol for 1 h at 4uC and then further purified in
20 mM Tris, 50 mM NaCl, pH 7.5 buffer, using a Superdex G200 column (GE
Healthcare). The peak corresponding to SIRT2 was pooled, concentrated to 10 mg/
mL and stored at 280uC.
SIRT2 activity assay. The activity of SIRT2 was assessed by high-performance liquid
chromatography (HPLC). Purified SIRT2 was incubated in 60 mL of reaction buffer
(20 mM Tris pH 8.0, 1 mM DTT, 1 mM NAD) with 32 mM H3K9, H2BK12, or
H4K16 acyl peptides, respectively, at 37uC for indicated time. The reaction was
quenched with 60 mL of 200 mMHCl and 320 mM acetic acid in methanol and spun
down at 18,000 g for 10 min to remove the precipitated SIRT2. The supernatant was
analyzed by HPLC on a Kinetex XB-C18 column (100 A, 75 mm 3 4.6 mm, 2.6 mm,
Phenomenex).
For kinetics, 0.2 mMSIRT2 was incubated in 60 mL of reaction buffer (20 mMTris
pH 8.0, 1 mM DTT, 1 mM NAD) with H3K9 acetyl or myristoyl peptides at varied
concentrations at 37uC for 2 min (H3K9 acetyl) or 3 min (H3K9 myristoyl). Peptide
concentration used for H3K9 acetyl was 1, 2, 4, 8, 16, 32, 64, 128 mM. Peptide
concentration used for H3K9 myristoyl was 0.25, 0.5, 1, 2, 4, 8, 16, 32 mM. The
reactions were quenched and analyzed as described above. The product and substrate
peaks were quantified by integrating their absorbance area at 280 nm, which were
converted to initial rates. The initial rates were then plotted against the peptide
concentrations and fitted using the Kaleidagraph program.
Crystallization of the SIRT2/BHJH-TM1. Crystals of SIRT2/BHJH-TM1 were
grown using the vapor diffusion hanging dropmethod. A solution containing 10 mg/
mL of SIRT2 in 20 mM Tris, 50 mM NaCl, pH 7.5 was preincubated on ice with
10 mM BHJH-TM1 for about 1 h. Hanging drops were formed by mixing 1.5 mL of
protein solution and 1.5 mL of well solution containing 25% (v/v) PEG 3350, 0.1 M
Hepes buffer, pH 7.5. Rod shape crystals grew in about 6 days to their maximum size
of 0.220.3 mm 3 0.120.2 mm.
X-rayData Collection and Processing.X-ray diffraction data for SIRT2/BHJH-TM1
were collected at Beamline A1 at the Cornell High Energy Synchrotron Source
(CHESS) using an ADSC Quantum 210 CCD detector. The data collection
temperature was 100 K. A total of 180u of data was collected with an oscillation range
of 1u per frame and an exposure time of 5 s per frame. X-ray diffraction data were
indexed, integrated, scaled, and merged using the program HKL200035 to 2.1 A˚
resolution. Data collection and processing statistics are summarized in Table 2.
Structure Determination and Refinement. The structure of SIRT2/BHJH-TM1 was
determined by molecular replacement using Phaser36 as implemented in the CCP437
program package. Amonomer of human SIRT2Apo-form (PDB ID: 3ZGO)was used
as the searchmodel. The initial model was refined to an R-factor of 28.74% and R-free
of 37.71% by using the maximum likelihood method implemented in REFMAC5 as
part of CCP437 program suite and was manually adjusted using COOT. After several
cycles of refinement and model building, BHJH-TM1 and water molecules were
added. The final model was refined to an R-factor of 22.1% and R-free of 27.3%. The
Ramachandran plot shows 91.7% of residues in the most favorable regions, 8.1% in
the allowed regions and 0.2% in generously allowed regions. No residue was in
disallowed regions. Refinement statistics are summarized in Table 2.
Data deposition. Atomic coordinates and structure factors for the reported crystal
structure have been deposited with the Protein Data Bank under accession code
4R8M.
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